RecruitingNCT07160816

A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

A Real-world, Multi-centre, Prospective, Non-interventional, Single-arm Study Investigating Glycaemic Control, Treatment Satisfaction and Adherence Associated With the Use of Insulin Icodec in People Living With Type 1 Diabetes

Sponsor

Novo Nordisk A/S

Enrollment

245 participants

Start Date

Aug 28, 2025

Study Type

OBSERVATIONAL

Conditions

Diabetes Mellitus, Type 1

Summary

The study will look at how well insulin icodec controls blood sugar levels in participants who have never used it before. Participants with type 1 diabetes (T1D) will be treated with insulin icodec as prescribed to by their doctor, in accordance with usual clinical practice. This study will last for about 22 to 30 weeks.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study follows people with Type 1 diabetes who have started using insulin icodec — a new once-weekly insulin injection (compared to daily insulin) — to see how well it controls blood sugar and how safe it is in real-world use. **You may be eligible if...** - You are 18 or older with a Type 1 diabetes diagnosis for at least 1 year - You have been on a multiple daily injection regimen (basal + bolus insulin) for at least 6 months - Your doctor has independently decided to start you on insulin icodec as part of your regular care - You have not previously used a once-weekly insulin **You may NOT be eligible if...** - You have already enrolled in this study before - You are currently receiving other insulin regimens that are incompatible with switching Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGInsulin icodec

Participants with T1D will be treated with commercially available insulin icodec.

Locations(37)

Hausärztliche und Diabetologische Praxis Pirna

Pirna, LÄK Sachsen, Germany

Zuckerpraxis Dr. Ewald Jammers

Bramsche, Germany

Studiengesellschaft Dres. Könemann/Steinmann GbR

Bünde, Germany

Diabeteszentrum-Do Dres. K U. Ch. Busch GbR

Dortmund, Germany

Diabeteszentrum Duisburg-Mitte

Duisburg, Germany

MVZ im Altstadt-Carree Fulda GmbH - Zentrum für klinische Studien

Fulda, Germany

Gemeinschaftspraxis Dr. Martin Grüneberg

Herne, Germany

Mesut Durmaz, Hof

Hof, Germany

Dr. Carola Lüke

Jerichow, Germany

Diabetespraxis Kiel

Kiel, Germany

Praxis Am Oberen Tor - Dr. Simon-Wagner

Lichtenfels, Germany

Diabetologie Dr. Eidenmüller

Marburg, Germany

Dr. Bernhard Landers

Mayen, Germany

Diabeteszentrum Bogenhausen

München, Germany

Medicover Neu-Ulm MVZ

Neu-Ulm, Germany

Diabetespraxis Oranienburg

Oranienburg, Germany

Diabetesschwerpunktpraxis Dr. Martina Lange

Rheinbach, Germany

Med.Versorgungszentrum Riesa-Dr. Bieler

Riesa, Germany

Dr. med. Carsten Schürfeld, GZ-Vauban

Saarlouis, Germany

Diabetespraxis Schorndorf Dr. Hensel

Schorndorf, Germany

Praxis Dr. Zimmermann

Sonsbeck, Germany

Endokrinologikum Ulm

Ulm, Germany

Diabetespraxis Viersen

Viersen, Germany

ASST FBF Sacco - Ospedale Fatebenefratelli e Oftalmico - Oculistica - Istituto Oftalmico

Milan, Lombardy, Italy

ASST Fatebenefratelli Sacco - Ospedale Macedonio Melloni

Milan, Lombardy, Italy

Ospedale San Raffaele S.r.l. - Unità Clinica Endocrinologia

Milan, Lombardy, Italy

ASST FBF Sacco - Ospedale Luigi Sacco

Milan, Lombardy, Italy

Azienda Sanitaria Locale Città di Torino - Ambulatorio Endocrinologia e Malattie Metaboliche

Turin, Piedmont, Italy

AUSL Toscana Nord Ovest - Ospedali Riuniti di Livorno - Diabetologia e Malattie del Metabolismo

Livorno, Tuscany, Italy

AUSL Toscana Nord Ovest - Cittadella della Salute Campo di Marte - Diabetologia Lucca e Valle del Serchio

Lucca, Tuscany, Italy

Azienda Ospedaliera Papa Giovanni XXIII

Bergamo, Italy

Azienda Ospedaliero-Universitaria Renato Dulbecco

Catanzaro, Italy

A.O.U. Università Studi della Campania "Luigi Vanvitelli"

Naples, Italy

Azienda Ospedaliera di Perugia;Ospedale S. Maria della Misericordia

Perugia, Italy

DIABETOLOGIA Ravenna AUSL della Romagna

Ravenna, Italy

Universita Degli Studi Di Roma La Sapienza - Policlinico Umberto I Medicina Sperimentale

Roma, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Dipartimento di scienze Mediche e Chirurgiche

Rome, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07160816

Related Trials

The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

NCT0721112621 locations

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

NCT0633413358 locations

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

NCT07222137107 locations

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

NCT073863401 location

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

NCT07222332132 locations